Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. The L (2018) GLOBOCAN 2018: counting the toll of cancer. Lancet 392(10152):985
2. Mottet N, van den Bergh RCN, Briers E, Cornford P, De Santis M, Fanti S et al (2022) EAU - ESTRO - ESUR - SIOG Guidelines on Prostate Cancer 2022. European Association of Urology Guidelines 2022 Edition. presented at the EAU Annual Congress Amsterdam 2022. Arnhem, The Netherlands: European Association of Urology Guidelines Office
3. NCCN (2021) Prostate Cancer (Version 2.2022). https://www.nccn.org/professionals/physician_gls/pdf/prostate_blocks.pdf
4. Heidegger I, Klocker H, Pichler R, Pircher A, Prokop W, Steiner E et al (2017) ProPSA and the Prostate Health Index as predictive markers for aggressiveness in low-risk prostate cancer-results from an international multicenter study. Prostate Cancer Prostatic Dis 20(3):271–275
5. de Cobelli O, Terracciano D, Tagliabue E, Raimondi S, Bottero D, Cioffi A et al (2015) Predicting pathological features at radical prostatectomy in patients with prostate cancer eligible for active surveillance by multiparametric magnetic resonance imaging. PLoS One 10(10):e0139696